Yu‐Yi Ling

1.5k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Yu‐Yi Ling is a scholar working on Molecular Biology, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu‐Yi Ling has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Biomedical Engineering and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu‐Yi Ling's work include RNA modifications and cancer (7 papers), Nanoplatforms for cancer theranostics (5 papers) and Cancer-related gene regulation (4 papers). Yu‐Yi Ling is often cited by papers focused on RNA modifications and cancer (7 papers), Nanoplatforms for cancer theranostics (5 papers) and Cancer-related gene regulation (4 papers). Yu‐Yi Ling collaborates with scholars based in China and United States. Yu‐Yi Ling's co-authors include Zong‐Wan Mao, Cai‐Ping Tan, Zhiyuan Li, Wenjin Wang, Hang Zhang, Jiexin Li, Hongsheng Wang, Yanmei Zhong, Xiaotong Zhou and Qian Cao and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Yu‐Yi Ling

21 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Carbonic Anhydrase IX (CAIX)‐Anchored Rhenium(I) Photosensitizer Evokes Pyroptosis for Enhanced Anti‐Tumor Immunity

2021 203 citations Xuxian Su, Wenjin Wang et al. Angewandte Chemie International Edition profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu‐Yi Ling China	15	662	376	222	208	181	21	1.1k
Qinyang Wang China	6	642 1.0×	205 0.5×	192 0.9×	175 0.8×	55 0.3×	9	875
Hua‐Zhen Xu China	17	302 0.5×	348 0.9×	243 1.1×	139 0.7×	150 0.8×	38	809
Rita Mendes Portugal	11	590 0.9×	414 1.1×	182 0.8×	415 2.0×	156 0.9×	16	1.4k
Lingpu Zhang China	13	273 0.4×	373 1.0×	145 0.7×	139 0.7×	177 1.0×	24	756
Mustafa Emre Gedik Türkiye	9	236 0.4×	681 1.8×	514 2.3×	189 0.9×	337 1.9×	17	1.1k
Rundi Song China	7	256 0.4×	413 1.1×	196 0.9×	146 0.7×	79 0.4×	10	707
Qingbing Wang China	17	315 0.5×	287 0.8×	91 0.4×	100 0.5×	141 0.8×	40	927
Aaron H. Colby United States	21	379 0.6×	331 0.9×	144 0.6×	163 0.8×	66 0.4×	33	956
Beilei Liu China	10	382 0.6×	143 0.4×	97 0.4×	291 1.4×	65 0.4×	20	883

Countries citing papers authored by Yu‐Yi Ling

Since Specialization

Citations

This map shows the geographic impact of Yu‐Yi Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Yi Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Yi Ling more than expected).

Fields of papers citing papers by Yu‐Yi Ling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Yi Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Yi Ling. The network helps show where Yu‐Yi Ling may publish in the future.

Co-authorship network of co-authors of Yu‐Yi Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Yi Ling. A scholar is included among the top collaborators of Yu‐Yi Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Yi Ling. Yu‐Yi Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ling, Yu‐Yi, et al.. (2025). Theranostic Rhenium Complexes as Suborganelle-Targeted Copper Ionophores To Stimulate Cuproptosis for Cancer Immunotherapy. ACS Applied Materials & Interfaces. 17(10). 15237–15249. 3 indexed citations

2.

Ling, Yu‐Yi, et al.. (2024). Self-assembly of a ruthenium-based cGAS-STING photoactivator for carrier-free cancer immunotherapy. European Journal of Medicinal Chemistry. 275. 116638–116638. 7 indexed citations

3.

Chen, Xiaoxiao, Kun Peng, Zhengyin Pan, et al.. (2024). Microtubule polymerization induced by iridium‐fullerene photosensitizers for cancer immunotherapy via dual‐reactive oxygen species regulation strategy. SHILAP Revista de lepidopterología. 5(6). 4 indexed citations

4.

Liang, Hao, et al.. (2024). Theranostic Rhenium(I)-Based ER-Phagy Retardant Promotes Immunogenic Cell Death. Journal of Medicinal Chemistry. 68(1). 338–347. 1 indexed citations

5.

Ling, Yu‐Yi, et al.. (2023). Photodegradation of carbonic anhydrase by iridium complexes for induction of immunogenic cell death under hypoxia. Inorganic Chemistry Frontiers. 10(11). 3284–3292. 12 indexed citations

6.

Zhou, Jiaying, Wenjin Wang, Chenyu Zhang, et al.. (2022). Ru(II)-modified TiO2 nanoparticles for hypoxia-adaptive photo-immunotherapy of oral squamous cell carcinoma. Biomaterials. 289. 121757–121757. 80 indexed citations

7.

Yu, Zhihong, De‐Xuan Liu, Yu‐Yi Ling, et al.. (2022). Periodate-based molecular perovskites as promising energetic biocidal agents. Science China Materials. 66(4). 1641–1648. 17 indexed citations

8.

Ling, Yu‐Yi, Xiaoyu Xia, Hao Liang, et al.. (2022). Simultaneous Photoactivation of cGAS‐STING Pathway and Pyroptosis by Platinum(II) Triphenylamine Complexes for Cancer Immunotherapy. Angewandte Chemie International Edition. 61(43). e202210988–e202210988. 97 indexed citations

9.

Ling, Yu‐Yi, Xiaoyu Xia, Hao Liang, et al.. (2022). Simultaneous Photoactivation of cGAS‐STING Pathway and Pyroptosis by Platinum(II) Triphenylamine Complexes for Cancer Immunotherapy. Angewandte Chemie. 134(43). 7 indexed citations

10.

Pan, Zhengyin, Yu‐Yi Ling, Hang Zhang, et al.. (2022). Pt(IV)-Deferasirox Prodrug Combats DNA Damage Repair by Regulating RNA N⁶-Methyladenosine Methylation. Journal of Medicinal Chemistry. 65(21). 14692–14700. 17 indexed citations

11.

Xie, Guoyou, Yu‐Yi Ling, Deyan Wu, et al.. (2021). A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities. Acta Pharmaceutica Sinica B. 12(2). 853–866. 70 indexed citations

12.

Wang, Wenjin, Yu‐Yi Ling, Yanmei Zhong, et al.. (2021). Ferroptosis‐Enhanced Cancer Immunity by a Ferrocene‐Appended Iridium(III) Diphosphine Complex. Angewandte Chemie International Edition. 61(16). e202115247–e202115247. 148 indexed citations

13.

Su, Xuxian, Wenjin Wang, Qian Cao, et al.. (2021). A Carbonic Anhydrase IX (CAIX)‐Anchored Rhenium(I) Photosensitizer Evokes Pyroptosis for Enhanced Anti‐Tumor Immunity. Angewandte Chemie. 134(8). 22 indexed citations

14.

Liang, Hao, Yu‐Yi Ling, Zhixin Huang, et al.. (2021). Real-time tracking of ER turnover during ERLAD by a rhenium complex via lifetime imaging. National Science Review. 9(7). nwab194–nwab194. 14 indexed citations

15.

Ling, Yu‐Yi, et al.. (2021). Ferroptosis‐Enhanced Cancer Immunity by a Ferrocene‐Appended Iridium(III) Diphosphine Complex. Angewandte Chemie. 134(16). 33 indexed citations

16.

Su, Xuxian, Wenjin Wang, Qian Cao, et al.. (2021). A Carbonic Anhydrase IX (CAIX)‐Anchored Rhenium(I) Photosensitizer Evokes Pyroptosis for Enhanced Anti‐Tumor Immunity. Angewandte Chemie International Edition. 61(8). e202115800–e202115800. 203 indexed citations breakdown →

17.

Li, Jiexin, Zhuojia Chen, Feng Chen, et al.. (2020). Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein. Nucleic Acids Research. 48(10). 5684–5694. 185 indexed citations

18.

An, Panpan, Feng Chen, Zihan Li, et al.. (2020). HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals. Oncogene. 39(26). 4956–4969. 49 indexed citations

19.

Zheng, Yupeng, Yu‐Yi Ling, Dongyang Zhang, et al.. (2020). Regulating Tumor N⁶‐Methyladenosine Methylation Landscape using Hypoxia‐Modulating OsS_x Nanoparticles. Small. 17(1). e2005086–e2005086. 18 indexed citations

20.

An, Panpan, Jiexin Li, Linlin Lu, et al.. (2018). Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals. European Journal of Pharmacology. 845. 16–23. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact